STRUCTURAL REQUIREMENTS FOR THE BINDING OF THE PITUITARY ADENYLATE-CYCLASE-ACTIVATING PEPTIDE TO RECEPTORS AND ADENYLATE-CYCLASE ACTIVATION IN PANCREATIC AND NEURONAL MEMBRANES
EUROPEAN JOURNAL OF BIOCHEMISTRY
|
1991年
/
195卷
/
02期
关键词:
D O I:
10.1111/j.1432-1033.1991.tb15734.x
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
PACAP (pituitary adenylate-cyclase-activating peptide)-binding receptors were investigated in membranes from the rat pancreatic acinar cell line, AR 4-2J, the rat hippocampus and the human neuroblastoma cell line NB-OK, by I-125-PACAP(1-27) (amino acid residues 1-27 of N-terminal amidated PACAP) binding and adenylate cyclase activation. The relative binding of I-125-PACAP(1-27) to the receptor, and ability to activate adenylate cyclase were PACAP greater-than-or-equal-to PACAP(1-27) > PACAP(2-38) > PACAP(1-9)-VIP(10-28)(PACAP-VIP) > PACAP(2-27) > [Ser9, Tyr13]VIP > [Tyr13]VIP greater-than-or-equal-to [Ser9]VIP greater-than-or-equal-to VIP(1-23)-PACAP(24-27)(VIP-PACAP) > VIP (vasoactive intestinal peptide). The N-terminal moiety of PACAP(1-27) was more important than the three amino acids at the C-terminus for I-125-PACAP(1-27)-binding site recognition. For rat pancreatic I-125-VIP-binding sites tested with I-125-VIP, the order of binding affinity was PACAP = PACAP(1-27) greater-than-or-equal-to VIP = [Ser9]VIP = [Tyr13]VIP = [Ser9,Tyr13]VIP greater-than-or-equal-to PACAP-VIP greater-than-or-equal-to VIP-PACAP > PACAP(2-38) = PACAP(2-27). Pancreatic I-125-VIP-binding sites, when compared to I-125-PACAP(1-27)-binding sites, showed little specificity and only weak coupling, so that PACAP and VIP-PACAP acted only as partial VIP agonists on adenylate cyclase.
机构:
HOP ST ANTOINE,CNRS,EQUIPE RECH 494,INSERM,UNITE RECH DIABETOL & ETUD RADIO IMMUNOL HORMONES,F-75571 PARIS 12,FRANCEHOP ST ANTOINE,CNRS,EQUIPE RECH 494,INSERM,UNITE RECH DIABETOL & ETUD RADIO IMMUNOL HORMONES,F-75571 PARIS 12,FRANCE
LABURTHE, M
BATAILLE, D
论文数: 0引用数: 0
h-index: 0
机构:
HOP ST ANTOINE,CNRS,EQUIPE RECH 494,INSERM,UNITE RECH DIABETOL & ETUD RADIO IMMUNOL HORMONES,F-75571 PARIS 12,FRANCEHOP ST ANTOINE,CNRS,EQUIPE RECH 494,INSERM,UNITE RECH DIABETOL & ETUD RADIO IMMUNOL HORMONES,F-75571 PARIS 12,FRANCE
BATAILLE, D
ROSSELIN, G
论文数: 0引用数: 0
h-index: 0
机构:
HOP ST ANTOINE,CNRS,EQUIPE RECH 494,INSERM,UNITE RECH DIABETOL & ETUD RADIO IMMUNOL HORMONES,F-75571 PARIS 12,FRANCEHOP ST ANTOINE,CNRS,EQUIPE RECH 494,INSERM,UNITE RECH DIABETOL & ETUD RADIO IMMUNOL HORMONES,F-75571 PARIS 12,FRANCE
机构:
HOP ST ANTOINE,CNRS,EQUIPE RECH 494,INSERM,UNITE RECH DIABETOL & ETUD RADIO IMMUNOL HORMONES,F-75571 PARIS 12,FRANCEHOP ST ANTOINE,CNRS,EQUIPE RECH 494,INSERM,UNITE RECH DIABETOL & ETUD RADIO IMMUNOL HORMONES,F-75571 PARIS 12,FRANCE
LABURTHE, M
BATAILLE, D
论文数: 0引用数: 0
h-index: 0
机构:
HOP ST ANTOINE,CNRS,EQUIPE RECH 494,INSERM,UNITE RECH DIABETOL & ETUD RADIO IMMUNOL HORMONES,F-75571 PARIS 12,FRANCEHOP ST ANTOINE,CNRS,EQUIPE RECH 494,INSERM,UNITE RECH DIABETOL & ETUD RADIO IMMUNOL HORMONES,F-75571 PARIS 12,FRANCE
BATAILLE, D
ROSSELIN, G
论文数: 0引用数: 0
h-index: 0
机构:
HOP ST ANTOINE,CNRS,EQUIPE RECH 494,INSERM,UNITE RECH DIABETOL & ETUD RADIO IMMUNOL HORMONES,F-75571 PARIS 12,FRANCEHOP ST ANTOINE,CNRS,EQUIPE RECH 494,INSERM,UNITE RECH DIABETOL & ETUD RADIO IMMUNOL HORMONES,F-75571 PARIS 12,FRANCE